Jacobs Levy Equity Management’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.7M Buy
+16,236
New +$4.11M 0.01% 458

Other funds holding ASND

Jacobs Levy Equity Management's ASND Position: Q3 2026 in Review

Jacobs Levy Equity Management opened a new position in Ascendis Pharma (ASND) in Q3 2026: 16,236 shares worth $3.7M. The stake represents 0.01% of the portfolio and ranks #458 among its holdings.

347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Jacobs Levy Equity Management held 16,236 shares of Ascendis Pharma worth $3.7M as of Q3 2026.
  • Ascendis Pharma was a new Jacobs Levy Equity Management position in Q3 2026.
  • Ascendis Pharma made up 0.01% of Jacobs Levy Equity Management's portfolio in Q3 2026, its #458 holding.
  • 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2026, filed 16 Nov 2026.